Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis Case report

被引:11
作者
Guppy, Kern H. [1 ]
Akins, Paul T. [1 ]
Moes, Gregory S. [1 ]
Prados, Michael D. [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurosurg, Kaiser Permanente Med Grp, Sacramento, CA 95825 USA
关键词
spinal cord oligodendroglioma; oligodendrogliomatosis; spinal cord tumor; 1p deletion; 19q deletion; cytogenetics; temozolomide; RAISED INTRACRANIAL-PRESSURE; ANAPLASTIC OLIGODENDROGLIOMA; LEPTOMENINGEAL OLIGODENDROGLIOMA; INTRAMEDULLARY OLIGODENDROGLIOMA; SURGICAL-MANAGEMENT; GLIOMATOSIS; TUMORS; DISSEMINATION; MENINGEAL; CHILDREN;
D O I
10.3171/2009.2.SPINE08853
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Oligodendroglioma of the spinal cord is a rare tumor that most often presents with spinal cord symptoms. The authors present a case of spinal cord oligodendroglioma that was associated with cerebral rather than spinal cord symptoms. A 30-year-old woman developed nausea, vomiting, and severe headaches. Magnetic resonance imaging of the brain showed meningeal enhancement. The patient underwent a craniotomy with biopsies of the meninges and brain. The biopsy findings revealed an abnormal arachnoid thickening without tumor cells. The patient later developed hydrocephalus and underwent shunt placement. Cerebrospinal fluid cytological findings were negative for tumor cells or infection. She was found to have a cervical cord lesion at C3-4 that was initially nonenhancing but later enhanced after Gd administration. Biopsy of the cord lesion with partial resection showed a WHO Grade 11 oligodendroglioma with 1p and 19q deletions determined by fluorescence in situ hybridization. Neurooncological treatment with tumor radiation and temozolomide (Temodor) resulted in improvement in radiographic findings, symptoms, and long-term survival. This paper presents an extensive review of the literature, which revealed only 2 other reported cases of cerebral symptoms in adults that preceded spinal cord symptoms in a patient with oligodendroglioma of the spinal cord. It is also the first reported case of oligodendroglimatosis due to a cervical spinal cord oligodendroglioma with I p and 19q deletions. (DOI: 10.3171/2009.2.SPINE08853)
引用
收藏
页码:557 / 563
页数:7
相关论文
共 50 条
  • [11] 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment
    Kouwenhoven, Mathilde C. M.
    Kros, Johan M.
    French, Pim J.
    Biemond-ter Stege, Elize M.
    Graveland, Wilfried J.
    Taphoorn, Martin J. B.
    Brandes, Alba A.
    van den Bent, Martin J.
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (15) : 2499 - 2503
  • [12] Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
    Gadji, Macoura
    Fortin, David
    Tsanaclis, Ana-Maria
    Drouin, Regen
    CANCER GENETICS AND CYTOGENETICS, 2009, 194 (01) : 12 - 22
  • [13] Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database
    Zreik, Jad
    Kerezoudis, Panagiotis
    Alvi, Mohammed Ali
    Yolcu, Yagiz U.
    Kizilbash, Sani H.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [14] Co-deletion of 1p/19q as Prognostic and Predictive Biomarker for Patients in West Bohemia with Anaplastic Oligodendroglioma
    Polivka, Jiri, Jr.
    Polivka, Jiri
    Repik, Tomas
    Rohan, Vladimir
    Hes, Ondrej
    Topolcan, Ondrej
    ANTICANCER RESEARCH, 2016, 36 (01) : 471 - 476
  • [15] Comparative molecular analysis of primary and recurrent oligodendroglioma that acquired imbalanced 1p/19q codeletion andTP53mutation: a case report
    Ono, Takahiro
    Reinhardt, Annekathrin
    Takahashi, Masataka
    Nanjo, Hiroshi
    Kamataki, Akihisa
    von Deimling, Andreas
    Shimizu, Hiroaki
    ACTA NEUROCHIRURGICA, 2020, 162 (12) : 3019 - 3024
  • [16] Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report
    Takami, Hirokazu
    Mukasa, Akitake
    Takayanagi, Shunsaku
    Koike, Tsukasa
    Matsuura, Reiko
    Ikemura, Masako
    Ushiku, Tetsuo
    Yoshikawa, Gakushi
    Shibahara, Junji
    Tanaka, Shota
    Saito, Nobuhito
    BRAIN TUMOR PATHOLOGY, 2023, 40 (01) : 26 - 34
  • [17] Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma
    Ma, Sirui
    Rudra, Soumon
    Campian, Jian L.
    Chheda, Milan G.
    Johanns, Tanner M.
    Ansstas, George
    Abraham, Christopher D.
    Chicoine, Michael R.
    Leuthardt, Eric C.
    Dowling, Joshua L.
    Dunn, Gavin P.
    Kim, Albert H.
    Huang, Jiayi
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [18] 1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma
    Andrews, Cyril
    Prayson, Richard A.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 46
  • [19] Spinal leptomeningeal oligodendrogliomatosis after resection of cerebral anaplastic oligodendoglioma with 1p19q Co-deletion - A case report
    Andres, Molina Jaque Felipe A.
    Fouzia, Ziad
    Sami, Raunio
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 73 : 314 - 316
  • [20] MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma
    Zhang, Shun
    Chiang, Gloria Chia-Yi
    Magge, Rajiv S.
    Fine, Howard Alan
    Ramakrishna, Rohan
    Chang, Eileen Wang
    Pulisetty, Tejas
    Wang, Yi
    Zhu, Wenzhen
    Kovanlikaya, Ilhami
    MAGNETIC RESONANCE IMAGING, 2019, 57 : 254 - 258